Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials

Abstract: Chronic lymphocytic leukemia patients with mutated immunoglobulin heavy-chain genes (IGHV-M), particularly those lacking poor-risk genomic lesions, often respond well to chemoimmunotherapy (CIT). DNA methylation profiling can subdivide early-stage patients into naive B-cell–like CLL (n-CLL...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Blood Advances
المؤلفون الرئيسيون:	Tomasz K. Wojdacz, Harindra E. Amarasinghe, Latha Kadalayil, Alice Beattie, Jade Forster, Stuart J. Blakemore, Helen Parker, Dean Bryant, Marta Larrayoz, Ruth Clifford, Pauline Robbe, Zadie A. Davis, Monica Else, Dena R. Howard, Basile Stamatopoulos, Andrew J. Steele, Richard Rosenquist, Andrew Collins, Andrew R. Pettitt, Peter Hillmen, Christoph Plass, Anna Schuh, Daniel Catovsky, David G. Oscier, Matthew J.J. Rose-Zerilli, Christopher C. Oakes, Jonathan C. Strefford
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2019-08-01
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2473952920300288